Emergent BioSolutions Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Emergent BioSolutions Inc. on April 7, 2010, covering events occurring on April 1, 2010. The filing discloses the entry into a material definitive agreement regarding strategic consulting services.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the specific consulting agreement:
- Consulting Fee: $15,000 per month.
- Expenses: Reimbursement of reasonable out-of-pocket expenses.
- Contract Term: One year (April 1, 2010, to April 1, 2011).
Material Changes
The Company replaced an expired consulting agreement with The Hauer Group with a new agreement effective April 1, 2010. The new agreement maintains the provision of strategic consulting and domestic and international marketing advice.
Management Commentary and Related Party Information
The agreement is with The Hauer Group, a firm owned solely by Jerome Hauer and his wife. Mr. Hauer serves as the Chief Executive Officer of The Hauer Group and is a member of Emergent BioSolutions Inc.'s Board of Directors. The filing identifies this as a related party transaction.
Investor Verification Checklist
- Verify the total annual cost of the consulting agreement ($180,000) relative to the Company's operating budget.
- Confirm the specific scope of "strategic consulting and marketing advice" to assess value.
- Review the Company's Board of Directors minutes for the approval process of this related party transaction.
- Check for any other pending or expired agreements with The Hauer Group not disclosed in this filing.